Bayer facing second trial amid claims weed killer bought from Monsanto causes cancer

Bayer facing second trial amid claims weed killer bought from Monsanto causes cancer
German chemicals and pharmaceuticals giant Bayer is set to face a second US trial over allegations that its glyphosate-based weed killer Roundup causes cancer.

This is six months after the company was rocked by a $289-million verdict by a California state court.

0
Like
Save